1. Home
  2. LPCN vs ESYN Comparison

LPCN vs ESYN Comparison

Compare LPCN & ESYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$1.48

Market Cap

18.7M

Sector

Health Care

ML Signal

HOLD

ESYN

EnerSyn Global Inc. Common Stock

N/A

Current Price

$1.89

Market Cap

19.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LPCN
ESYN
Founded
1997
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7M
19.8M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
LPCN
ESYN
Price
$1.48
$1.89
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $5.00
N/A
AVG Volume (30 Days)
★ 1.6M
15.5K
Earning Date
11-05-2026
10-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.37
EPS
N/A
★ N/A
Revenue
★ $1,976,677.00
$866,926.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18.02
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.59
$1.88
52 Week High
$12.37
$2.68

Technical Indicators

Market Signals
Indicator
LPCN
ESYN
Relative Strength Index (RSI) 25.40 26.23
Support Level N/A N/A
Resistance Level $2.40 $2.20
Average True Range (ATR) 0.19 0.16
MACD -0.05 -0.02
Stochastic Oscillator 0.90 14.39

Price Performance

Historical Comparison
LPCN
ESYN

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About ESYN EnerSyn Global Inc. Common Stock

EnerSyn Global Inc, formerly HWH International Inc and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore. The Company is presently developing Hapi Marketplace, a business-to-consumer platform featuring diverse product categories, and Hapi Wealth Builder, an educational program focused on wealth-building strategies.

Share on Social Networks: